Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Sales, net	$ 25,580	$ 19,495	$ 70,472	$ 62,374
Cost of sales	9,340	7,526	27,083	24,531
Gross profit	16,240	11,969	43,389	37,843
Operating expenses:
Sales and marketing	7,044	6,035	20,753	19,918
Research and development	1,290	1,241	4,701	3,799
General and administrative	6,304	5,840	17,320	19,557
Total operating expenses	14,638	13,116	42,774	43,274
Operating income (loss)	1,602	(1,147)	615	(5,431)
Nonoperating income:
Interest income, net	276	188	756	379
Net income (loss)	$ 1,878	$ (959)	$ 1,371	$ (5,052)
Net income (loss) per share attributable to ChromaDex Corporation:
Basic (in dollar per share)	$ 0.02	$ (0.01)	$ 0.02	$ (0.07)
Diluted (in dollar per share)	$ 0.02	$ (0.01)	$ 0.02	$ (0.07)
Weighted average common shares outstanding:
Basic (in shares)	75,972	75,050	75,588	74,938
Diluted (in shares)	77,768	75,050	76,804	74,938